BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31183451)

  • 1. Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases.
    Kepenekian V; Muller A; Valette PJ; Rousset P; Chauvenet M; Phelip G; Walter T; Adham M; Glehen O; Passot G
    BJS Open; 2019 Jun; 3(3):344-353. PubMed ID: 31183451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of Missing Liver Metastases After Fiducial Placement.
    Passot G; Odisio BC; Zorzi D; Mahvash A; Gupta S; Wallace MJ; Kim BJ; Yamashita S; Conrad C; Aloia TA; Vauthey JN; Chun YS
    J Gastrointest Surg; 2016 Jun; 20(6):1173-8. PubMed ID: 26791387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy.
    Araujo RLC; Milani JM; Armentano DP; Moreira RB; Pinto GSF; de Castro LA; Lucchesi FR
    J Surg Oncol; 2020 Apr; 121(5):848-856. PubMed ID: 31773747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
    Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
    Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases.
    Nielsen K; Scheffer HJ; Volders JH; van der Vorst MJ; van Tilborg AA; Comans EF; de Lange-de Klerk ES; Sietses C; Meijer S; Meijerink MR; van den Tol MP
    World J Surg; 2016 Aug; 40(8):1951-8. PubMed ID: 27220509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic two-stage hepatectomy for bilobar colorectal liver metastases.
    Fuks D; Nomi T; Ogiso S; Gelli M; Velayutham V; Conrad C; Louvet C; Gayet B
    Br J Surg; 2015 Dec; 102(13):1684-90. PubMed ID: 26392212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
    Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
    Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented Reality Guidance for the Resection of Missing Colorectal Liver Metastases: An Initial Experience.
    Ntourakis D; Memeo R; Soler L; Marescaux J; Mutter D; Pessaux P
    World J Surg; 2016 Feb; 40(2):419-26. PubMed ID: 26316112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.
    Nagayama S; Hasegawa S; Hida K; Kawada K; Hatano E; Nakamura K; Seo S; Taura K; Yasuchika K; Matsuo T; Zaima M; Kanazawa A; Terajima H; Tada M; Adachi Y; Nishitai R; Manaka D; Yoshimura T; Doi K; Horimatsu T; Mitsuyoshi A; Yoshimura K; Niimi M; Matsumoto S; Sakai Y; Uemoto S
    Int J Clin Oncol; 2017 Apr; 22(2):316-323. PubMed ID: 27752787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.
    Abdalla EK; Bauer TW; Chun YS; D'Angelica M; Kooby DA; Jarnagin WR
    HPB (Oxford); 2013 Feb; 15(2):119-30. PubMed ID: 23297723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat hepatic resection in patients with colorectal liver metastases.
    Lee H; Choi SH; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi DW; Jung KU; Chun HK
    World J Gastroenterol; 2015 Feb; 21(7):2124-30. PubMed ID: 25717247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of contrast-enhanced intraoperative ultrasound on operation strategy in case of colorectal liver metastasis.
    Schulz A; Dormagen JB; Drolsum A; Bjørnbeth BA; Labori KJ; Kløw NE
    Acta Radiol; 2012 Dec; 53(10):1081-7. PubMed ID: 23081954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.
    Nakano H; Oussoultzoglou E; Rosso E; Casnedi S; Chenard-Neu MP; Dufour P; Bachellier P; Jaeck D
    Ann Surg; 2008 Jan; 247(1):118-24. PubMed ID: 18156931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer planned, image-guided combined resection and ablation for bilobar colorectal liver metastases.
    Banz VM; Baechtold M; Weber S; Peterhans M; Inderbitzin D; Candinas D
    World J Gastroenterol; 2014 Oct; 20(40):14992-6. PubMed ID: 25356061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.